Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Depreciation and Depletion: 2016-2024

Historic Depreciation and Depletion for Whitehawk Therapeutics (WHWK) over the last 8 years, with Dec 2024 value amounting to $200,000.

  • Whitehawk Therapeutics' Depreciation and Depletion fell 88.01% to $5,600 in Q3 2025 from the same period last year, while for Sep 2025 it was $131,900, marking a year-over-year decrease of 40.40%. This contributed to the annual value of $200,000 for FY2024, which is negligibly% changed negligibly from last year.
  • Whitehawk Therapeutics' Depreciation and Depletion amounted to $200,000 in FY2024, which was down 0.00% from $200,000 recorded in FY2023.
  • Whitehawk Therapeutics' Depreciation and Depletion's 5-year high stood at $200,000 during FY2023, with a 5-year trough of $61,482 in FY2020.
  • Its 3-year average for Depreciation and Depletion is $166,667, with a median of $200,000 in 2024.
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first decreased by 19.63% in 2020, then surged by 100.00% in 2023.
  • Whitehawk Therapeutics' Depreciation and Depletion (Yearly) stood at $61,482 in 2020, then reached $100,000 in 2022, then surged by 100.00% to $200,000 in 2023, then remained steady at $200,000 in 2024.